Celldex Therapeutics - 31 Year Stock Price History | CLDX
Historical daily share price chart and data for Celldex Therapeutics since 1990 adjusted for splits. The latest closing stock price for Celldex Therapeutics as of September 23, 2021 is 55.99.
- The all-time high Celldex Therapeutics stock closing price was 3014.70 on March 06, 2000.
- The Celldex Therapeutics 52-week high stock price is 56.17, which is 0.3% above the current share price.
- The Celldex Therapeutics 52-week low stock price is 12.82, which is 77.1% below the current share price.
- The average Celldex Therapeutics stock price for the last 52 weeks is 28.24.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Celldex Therapeutics Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2021 |
32.0420 |
19.1000 |
55.9900 |
16.1900 |
55.9900 |
219.58% |
| 2020 |
9.1735 |
2.2500 |
22.7500 |
1.5500 |
17.5200 |
685.65% |
| 2019 |
3.2990 |
3.7571 |
10.3553 |
2.0500 |
2.2300 |
-24.84% |
| 2018 |
15.8068 |
43.7781 |
46.0270 |
2.9235 |
2.9670 |
-93.03% |
| 2017 |
44.1016 |
54.1229 |
59.3703 |
33.5832 |
42.5787 |
-19.77% |
| 2016 |
73.3586 |
224.7376 |
231.9340 |
43.0285 |
53.0735 |
-77.42% |
| 2015 |
312.9721 |
276.0120 |
476.4618 |
155.6222 |
235.0825 |
-14.08% |
| 2014 |
267.4752 |
368.9655 |
473.6132 |
166.2669 |
273.6132 |
-24.62% |
| 2013 |
266.9407 |
104.9475 |
567.1664 |
104.6477 |
362.9685 |
260.80% |
| 2012 |
75.1824 |
41.6792 |
103.8981 |
41.5292 |
100.5997 |
158.08% |
| 2011 |
49.8028 |
63.2684 |
66.8666 |
31.6342 |
38.9805 |
-36.89% |
| 2010 |
76.6517 |
70.6147 |
141.3793 |
51.2744 |
61.7691 |
-11.78% |
| 2009 |
101.9175 |
119.7901 |
172.4138 |
62.9685 |
70.0150 |
-41.04% |
| 2008 |
155.2623 |
100.7899 |
269.5652 |
67.9160 |
118.7406 |
31.95% |
| 2007 |
161.1736 |
246.5754 |
278.9722 |
73.7926 |
89.9910 |
-62.69% |
| 2006 |
299.2865 |
338.3662 |
457.1544 |
228.5772 |
241.1759 |
-28.72% |
| 2005 |
271.9586 |
368.9632 |
390.5610 |
208.7792 |
338.3662 |
-6.47% |
| 2004 |
420.2081 |
496.7504 |
678.5323 |
282.5718 |
361.7639 |
-26.64% |
| 2003 |
357.5000 |
210.5790 |
554.3447 |
174.5826 |
493.1508 |
142.48% |
| 2002 |
271.4872 |
707.3294 |
721.7280 |
129.5871 |
203.3797 |
-71.82% |
| 2001 |
845.8938 |
1159.0843 |
1519.0484 |
404.9596 |
721.7280 |
-41.63% |
| 2000 |
1471.3889 |
415.7585 |
3014.6991 |
370.7630 |
1236.4766 |
178.14% |
| 1999 |
331.9312 |
349.1652 |
561.5440 |
201.5799 |
444.5556 |
41.14% |
| 1998 |
391.2824 |
404.9596 |
809.9192 |
190.7810 |
314.9686 |
-28.28% |
| 1997 |
333.6141 |
291.5709 |
568.7432 |
230.3770 |
439.1562 |
50.62% |
| 1996 |
484.5131 |
584.9416 |
786.5215 |
286.1714 |
291.5709 |
-48.08% |
| 1995 |
650.5994 |
449.9551 |
966.5035 |
426.5574 |
561.5440 |
24.80% |
| 1994 |
721.9137 |
1529.8473 |
1529.8473 |
381.5619 |
449.9551 |
-67.74% |
| 1993 |
1211.2862 |
1304.8698 |
1461.4541 |
854.9147 |
1394.8608 |
5.16% |
| 1992 |
1461.5179 |
2226.3778 |
2519.7485 |
1056.4946 |
1326.4676 |
-33.00% |
| 1991 |
1256.0470 |
516.5484 |
2474.7530 |
516.5484 |
1979.8024 |
274.15% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.524B |
$0.007B |
|
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
|
